APO Research

APO RESEARCH · REPORT

Wearable Neuromodulation Devices

Selected research

Industry Growth & Trends

Global Wearable Neuromodulation Devices Industry Growth and Trends Forecast to 2032

Market perspective

The global Wearable Neuromodulation Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Wearable Neuromodulation Devices include Brainco, NeuroSky, Muse, Halo Neuroscience, Caputron, Nerivio, Magnus, Emotiv and Thync, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Wearable Neuromodulation Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Wearable Neuromodulation Devices market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Wearable Neuromodulation Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Wearable Neuromodulation Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Wearable Neuromodulation Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Wearable Neuromodulation Devices Market by Company

Brainco

NeuroSky

Muse

Halo Neuroscience

Caputron

Nerivio

Magnus

Emotiv

Thync

Wearable Neuromodulation Devices Segment by Type

Head-mounted

Ear-mounted

Arm-mounted

Others

Wearable Neuromodulation Devices Segment by Application

Adults

Children

Wearable Neuromodulation Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Neuromodulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wearable Neuromodulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Neuromodulation Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Wearable Neuromodulation Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Wearable Neuromodulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Head-mounted Table 2. Major Company of Ear-mounted Table 3. Major Company of Arm-mounted Table 4. Major Company of Others Table 5. Global Wearable Neuromodulation Devices Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Wearable Neuromodulation Devices Sales by Type (2021-2026) & (k units) Table 7. Global Wearable Neuromodulation Devices Sales Market Share in Volume by Type (2021-2026) Table 8. Global Wearable Neuromodulation Devices Sales by Type (2021-2026) & (US$ Million) Table 9. Global Wearable Neuromodulation Devices Sales Market Share in Value by Type (2021-2026) Table 10. Global Wearable Neuromodulation Devices Price by Type (2021-2026) & (USD/unit) Table 11. Global Wearable Neuromodulation Devices Sales by Type (2027-2032) & (k units) Table 12. Global Wearable Neuromodulation Devices Sales Market Share in Volume by Type (2027-2032) Table 13. Global Wearable Neuromodulation Devices Sales by Type (2027-2032) & (US$ Million) Table 14. Global Wearable Neuromodulation Devices Sales Market Share in Value by Type (2027-2032) Table 15. Global Wearable Neuromodulation Devices Price by Type (2027-2032) & (USD/unit) Table 16. North America Wearable Neuromodulation Devices Sales by Type (2021-2026) & (k units) Table 17. North America Wearable Neuromodulation Devices Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Wearable Neuromodulation Devices Sales by Type (2021-2026) & (k units) Table 19. Europe Wearable Neuromodulation Devices Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Wearable Neuromodulation Devices Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Wearable Neuromodulation Devices Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Wearable Neuromodulation Devices Sales by Type (2021-2026) & (k units) Table 23. Latin America Wearable Neuromodulation Devices Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Wearable Neuromodulation Devices Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Wearable Neuromodulation Devices Sales by Type (2021-2026) & (US$ Million) Table 26. Wearable Neuromodulation Devices Industry Trends Table 27. Wearable Neuromodulation Devices Industry Drivers Table 28. Wearable Neuromodulation Devices Industry Opportunities and Challenges Table 29. Wearable Neuromodulation Devices Industry Restraints Table 30. Global Wearable Neuromodulation Devices Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Wearable Neuromodulation Devices Revenue Market Share by Company (2021-2026) Table 32. Global Wearable Neuromodulation Devices Sales by Company (2021-2026) & (k units) Table 33. Global Wearable Neuromodulation Devices Sales Share by Company (2021-2026) Table 34. Global Wearable Neuromodulation Devices Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Wearable Neuromodulation Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Wearable Neuromodulation Devices Major Company Production Sites and Headquarters Table 37. Global Wearable Neuromodulation Devices Company, Product Type & Application Table 38. Global Wearable Neuromodulation Devices Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Wearable Neuromodulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Wearable Neuromodulation Devices Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Wearable Neuromodulation Devices Sales by Region (2021-2026) & (k units) Table 43. Global Wearable Neuromodulation Devices Sales Market Share in Volume by Region (2021-2026) Table 44. Global Wearable Neuromodulation Devices Sales by Region (2021-2026) & (US$ Million) Table 45. Global Wearable Neuromodulation Devices Sales Market Share in Value by Region (2021-2026) Table 46. Global Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Wearable Neuromodulation Devices Sales by Region (2027-2032) & (k units) Table 48. Global Wearable Neuromodulation Devices Sales Market Share in Volume by Region (2027-2032) Table 49. Global Wearable Neuromodulation Devices Sales by Region (2027-2032) & (US$ Million) Table 50. Global Wearable Neuromodulation Devices Sales Market Share in Value by Region (2027-2032) Table 51. Global Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Wearable Neuromodulation Devices Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Wearable Neuromodulation Devices Sales by Application (2021-2026) & (k units) Table 54. Global Wearable Neuromodulation Devices Sales Market Share in Volume by Application (2021-2026) Table 55. Global Wearable Neuromodulation Devices Sales by Application (2021-2026) & (US$ Million) Table 56. Global Wearable Neuromodulation Devices Sales Market Share in Value by Application (2021-2026) Table 57. Global Wearable Neuromodulation Devices Price by Application (2021-2026) & (USD/unit) Table 58. Global Wearable Neuromodulation Devices Sales by Application (2027-2032) & (k units) Table 59. Global Wearable Neuromodulation Devices Sales Market Share in Volume by Application (2027-2032) Table 60. Global Wearable Neuromodulation Devices Sales by Application (2027-2032) & (US$ Million) Table 61. Global Wearable Neuromodulation Devices Sales Market Share in Value by Application (2027-2032) Table 62. Global Wearable Neuromodulation Devices Price by Application (2027-2032) & (USD/unit) Table 63. North America Wearable Neuromodulation Devices Sales by Application (2021-2026) & (k units) Table 64. North America Wearable Neuromodulation Devices Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Wearable Neuromodulation Devices Sales by Application (2021-2026) & (k units) Table 66. Europe Wearable Neuromodulation Devices Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Wearable Neuromodulation Devices Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Wearable Neuromodulation Devices Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Wearable Neuromodulation Devices Sales by Application (2021-2026) & (k units) Table 70. Latin America Wearable Neuromodulation Devices Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Wearable Neuromodulation Devices Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Wearable Neuromodulation Devices Sales by Application (2021-2026) & (US$ Million) Table 73. Brainco Company Information Table 74. Brainco Business Overview Table 75. Brainco Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Brainco Wearable Neuromodulation Devices Product Portfolio Table 77. Brainco Recent Development Table 78. NeuroSky Company Information Table 79. NeuroSky Business Overview Table 80. NeuroSky Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. NeuroSky Wearable Neuromodulation Devices Product Portfolio Table 82. NeuroSky Recent Development Table 83. Muse Company Information Table 84. Muse Business Overview Table 85. Muse Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Muse Wearable Neuromodulation Devices Product Portfolio Table 87. Muse Recent Development Table 88. Halo Neuroscience Company Information Table 89. Halo Neuroscience Business Overview Table 90. Halo Neuroscience Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio Table 92. Halo Neuroscience Recent Development Table 93. Caputron Company Information Table 94. Caputron Business Overview Table 95. Caputron Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Caputron Wearable Neuromodulation Devices Product Portfolio Table 97. Caputron Recent Development Table 98. Nerivio Company Information Table 99. Nerivio Business Overview Table 100. Nerivio Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Nerivio Wearable Neuromodulation Devices Product Portfolio Table 102. Nerivio Recent Development Table 103. Magnus Company Information Table 104. Magnus Business Overview Table 105. Magnus Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Magnus Wearable Neuromodulation Devices Product Portfolio Table 107. Magnus Recent Development Table 108. Emotiv Company Information Table 109. Emotiv Business Overview Table 110. Emotiv Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Emotiv Wearable Neuromodulation Devices Product Portfolio Table 112. Emotiv Recent Development Table 113. Thync Company Information Table 114. Thync Business Overview Table 115. Thync Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Thync Wearable Neuromodulation Devices Product Portfolio Table 117. Thync Recent Development Table 118. North America Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. North America Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 120. North America Wearable Neuromodulation Devices Sales Market Share by Country (2021-2026) Table 121. North America Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032) & (k units) Table 122. North America Wearable Neuromodulation Devices Sales Market Share Forecast by Country (2027-2032) Table 123. North America Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Wearable Neuromodulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Wearable Neuromodulation Devices Market Share by Country (2021-2026) Table 126. North America Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Wearable Neuromodulation Devices Market Share Forecast by Country (2027-2032) Table 128. Europe Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Europe Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 130. Europe Wearable Neuromodulation Devices Sales Market Share by Country (2021-2026) Table 131. Europe Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032) & (k units) Table 132. Europe Wearable Neuromodulation Devices Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Wearable Neuromodulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Wearable Neuromodulation Devices Market Share by Country (2021-2026) Table 136. Europe Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Wearable Neuromodulation Devices Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 140. Asia-Pacific Wearable Neuromodulation Devices Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032) & (k units) Table 142. Asia-Pacific Wearable Neuromodulation Devices Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Wearable Neuromodulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Wearable Neuromodulation Devices Market Share by Country (2021-2026) Table 146. Asia-Pacific Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Wearable Neuromodulation Devices Market Share Forecast by Country (2027-2032) Table 148. Latin America Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Latin America Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 150. Latin America Wearable Neuromodulation Devices Sales Market Share by Country (2021-2026) Table 151. Latin America Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032) & (k units) Table 152. Latin America Wearable Neuromodulation Devices Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Wearable Neuromodulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Wearable Neuromodulation Devices Market Share by Country (2021-2026) Table 156. Latin America Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Wearable Neuromodulation Devices Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 160. Middle East and Africa Wearable Neuromodulation Devices Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032) & (k units) Table 162. Middle East and Africa Wearable Neuromodulation Devices Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Wearable Neuromodulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Wearable Neuromodulation Devices Market Share by Country (2021-2026) Table 166. Middle East and Africa Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Wearable Neuromodulation Devices Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Wearable Neuromodulation Devices Distributors List Table 171. Wearable Neuromodulation Devices Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Wearable Neuromodulation Devices Image Figure 2. Global Wearable Neuromodulation Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wearable Neuromodulation Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Wearable Neuromodulation Devices Sales (2021-2032) & (k units) Figure 5. Head-mounted Image Figure 6. Global Head-mounted Sales YoY Growth (2021-2032) & (k units) Figure 7. Ear-mounted Image Figure 8. Global Ear-mounted Sales YoY Growth (2021-2032) & (k units) Figure 9. Arm-mounted Image Figure 10. Global Arm-mounted Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Wearable Neuromodulation Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Wearable Neuromodulation Devices Market Share by Type 2025 VS 2032 Figure 15. North America Wearable Neuromodulation Devices Sales Market Share in Volume by Type in 2025 Figure 16. North America Wearable Neuromodulation Devices Sales Market Share in Value by Type in 2025 Figure 17. Europe Wearable Neuromodulation Devices Sales Market Share in Volume by Type in 2025 Figure 18. Europe Wearable Neuromodulation Devices Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Wearable Neuromodulation Devices Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Wearable Neuromodulation Devices Sales Market Share in Value by Type in 2025 Figure 21. Latin America Wearable Neuromodulation Devices Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Wearable Neuromodulation Devices Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Wearable Neuromodulation Devices Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Wearable Neuromodulation Devices Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Wearable Neuromodulation Devices Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 29. Children Image Figure 30. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Wearable Neuromodulation Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Wearable Neuromodulation Devices Market Share by Application 2025 VS 2032 Figure 33. North America Wearable Neuromodulation Devices Sales Market Share in Volume by Application in 2025 Figure 34. North America Wearable Neuromodulation Devices Sales Market Share in Value by Application in 2025 Figure 35. Europe Wearable Neuromodulation Devices Sales Market Share in Volume by Application in 2025 Figure 36. Europe Wearable Neuromodulation Devices Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Wearable Neuromodulation Devices Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Wearable Neuromodulation Devices Sales Market Share in Value by Application in 2025 Figure 39. Latin America Wearable Neuromodulation Devices Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Wearable Neuromodulation Devices Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Wearable Neuromodulation Devices Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Wearable Neuromodulation Devices Sales Market Share in Value by Application in 2025 Figure 43. North America Wearable Neuromodulation Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Wearable Neuromodulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Wearable Neuromodulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Wearable Neuromodulation Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Wearable Neuromodulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Wearable Neuromodulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Wearable Neuromodulation Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Wearable Neuromodulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Wearable Neuromodulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Wearable Neuromodulation Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Wearable Neuromodulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Wearable Neuromodulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Wearable Neuromodulation Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Wearable Neuromodulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Wearable Neuromodulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Wearable Neuromodulation Devices Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Wearable Neuromodulation Devices Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Head-mounted
  • Ear-mounted
  • Arm-mounted
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Brainco
  • NeuroSky
  • Muse
  • Halo Neuroscience
  • Caputron
  • Nerivio
  • Magnus
  • Emotiv
  • Thync

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Wearable Neuromodulation Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Wearable Neuromodulation Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Wearable Neuromodulation Devices Market by Type
  6. 1.3.1 Head-mounted
  7. 1.3.2 Ear-mounted
  8. 1.3.3 Arm-mounted
  9. 1.3.4 Others
  10. 1.4 Global Wearable Neuromodulation Devices Market Size by Type
  11. 1.4.1 Global Wearable Neuromodulation Devices Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Wearable Neuromodulation Devices Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Wearable Neuromodulation Devices Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Wearable Neuromodulation Devices Industry Trends
  2. 2.2 Wearable Neuromodulation Devices Industry Drivers
  3. 2.3 Wearable Neuromodulation Devices Industry Opportunities and Challenges
  4. 2.4 Wearable Neuromodulation Devices Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Wearable Neuromodulation Devices Revenue (2021-2026)
  2. 3.2 Global Top Players by Wearable Neuromodulation Devices Sales (2021-2026)
  3. 3.3 Global Top Players by Wearable Neuromodulation Devices Price (2021-2026)
  4. 3.4 Global Wearable Neuromodulation Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Wearable Neuromodulation Devices Major Company Production Sites & Headquarters
  6. 3.6 Global Wearable Neuromodulation Devices Company, Product Type & Application
  7. 3.7 Global Wearable Neuromodulation Devices Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Wearable Neuromodulation Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Wearable Neuromodulation Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Wearable Neuromodulation Devices Tier 1, Tier 2, and Tier 3
4 Wearable Neuromodulation Devices Regional Status and Outlook
  1. 4.1 Global Wearable Neuromodulation Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Wearable Neuromodulation Devices Historic Market Size by Region
  3. 4.2.1 Global Wearable Neuromodulation Devices Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Wearable Neuromodulation Devices Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Wearable Neuromodulation Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Wearable Neuromodulation Devices Forecasted Market Size by Region
  7. 4.3.1 Global Wearable Neuromodulation Devices Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Wearable Neuromodulation Devices Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Wearable Neuromodulation Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Wearable Neuromodulation Devices by Application
  1. 5.1 Wearable Neuromodulation Devices Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Wearable Neuromodulation Devices Market Size by Application
  5. 5.2.1 Global Wearable Neuromodulation Devices Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Wearable Neuromodulation Devices Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Wearable Neuromodulation Devices Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Brainco
  2. 6.1.1 Brainco Company Information
  3. 6.1.2 Brainco Business Overview
  4. 6.1.3 Brainco Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Brainco Wearable Neuromodulation Devices Product Portfolio
  6. 6.1.5 Brainco Recent Developments
  7. 6.2 NeuroSky
  8. 6.2.1 NeuroSky Company Information
  9. 6.2.2 NeuroSky Business Overview
  10. 6.2.3 NeuroSky Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 NeuroSky Wearable Neuromodulation Devices Product Portfolio
  12. 6.2.5 NeuroSky Recent Developments
  13. 6.3 Muse
  14. 6.3.1 Muse Company Information
  15. 6.3.2 Muse Business Overview
  16. 6.3.3 Muse Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Muse Wearable Neuromodulation Devices Product Portfolio
  18. 6.3.5 Muse Recent Developments
  19. 6.4 Halo Neuroscience
  20. 6.4.1 Halo Neuroscience Company Information
  21. 6.4.2 Halo Neuroscience Business Overview
  22. 6.4.3 Halo Neuroscience Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio
  24. 6.4.5 Halo Neuroscience Recent Developments
  25. 6.5 Caputron
  26. 6.5.1 Caputron Company Information
  27. 6.5.2 Caputron Business Overview
  28. 6.5.3 Caputron Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Caputron Wearable Neuromodulation Devices Product Portfolio
  30. 6.5.5 Caputron Recent Developments
  31. 6.6 Nerivio
  32. 6.6.1 Nerivio Company Information
  33. 6.6.2 Nerivio Business Overview
  34. 6.6.3 Nerivio Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Nerivio Wearable Neuromodulation Devices Product Portfolio
  36. 6.6.5 Nerivio Recent Developments
  37. 6.7 Magnus
  38. 6.7.1 Magnus Company Information
  39. 6.7.2 Magnus Business Overview
  40. 6.7.3 Magnus Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Magnus Wearable Neuromodulation Devices Product Portfolio
  42. 6.7.5 Magnus Recent Developments
  43. 6.8 Emotiv
  44. 6.8.1 Emotiv Company Information
  45. 6.8.2 Emotiv Business Overview
  46. 6.8.3 Emotiv Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Emotiv Wearable Neuromodulation Devices Product Portfolio
  48. 6.8.5 Emotiv Recent Developments
  49. 6.9 Thync
  50. 6.9.1 Thync Company Information
  51. 6.9.2 Thync Business Overview
  52. 6.9.3 Thync Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Thync Wearable Neuromodulation Devices Product Portfolio
  54. 6.9.5 Thync Recent Developments
7 North America by Country
  1. 7.1 North America Wearable Neuromodulation Devices Sales by Country
  2. 7.1.1 North America Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Wearable Neuromodulation Devices Sales by Country (2021-2026)
  4. 7.1.3 North America Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
  5. 7.2 North America Wearable Neuromodulation Devices Market Size by Country
  6. 7.2.1 North America Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Wearable Neuromodulation Devices Market Size by Country (2021-2026)
  8. 7.2.3 North America Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Wearable Neuromodulation Devices Sales by Country
  2. 8.1.1 Europe Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Wearable Neuromodulation Devices Sales by Country (2021-2026)
  4. 8.1.3 Europe Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Wearable Neuromodulation Devices Market Size by Country
  6. 8.2.1 Europe Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Wearable Neuromodulation Devices Market Size by Country (2021-2026)
  8. 8.2.3 Europe Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Wearable Neuromodulation Devices Sales by Country
  2. 9.1.1 Asia-Pacific Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Wearable Neuromodulation Devices Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Wearable Neuromodulation Devices Market Size by Country
  6. 9.2.1 Asia-Pacific Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Wearable Neuromodulation Devices Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Wearable Neuromodulation Devices Sales by Country
  2. 10.1.1 South America Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Wearable Neuromodulation Devices Sales by Country (2021-2026)
  4. 10.1.3 South America Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
  5. 10.2 South America Wearable Neuromodulation Devices Market Size by Country
  6. 10.2.1 South America Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Wearable Neuromodulation Devices Market Size by Country (2021-2026)
  8. 10.2.3 South America Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Wearable Neuromodulation Devices Sales by Country
  2. 11.1.1 Middle East and Africa Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Wearable Neuromodulation Devices Market Size by Country
  6. 11.2.1 Middle East and Africa Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Wearable Neuromodulation Devices Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Wearable Neuromodulation Devices Value Chain Analysis
  2. 12.1.1 Wearable Neuromodulation Devices Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Wearable Neuromodulation Devices Production Mode & Process
  7. 12.2 Wearable Neuromodulation Devices Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Wearable Neuromodulation Devices Distributors
  10. 12.2.3 Wearable Neuromodulation Devices Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research